Tarnate, Renerose .
HRN: 28-15-34 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2025
CEFUROXIME 500MG (TAB)
11/24/2025
12/01/2025
PO
500 Mg
BID
Thickly MSAF S/P NSVD With RMLE
Checking Initial Appropriateness
11/24/2025
METRONIDAZOLE 500MG (TAB)
11/24/2025
12/01/2025
PO
500 Mg
TID
Thickly MSAF S/P NSVD With RMLE
Checking Initial Appropriateness
11/27/2025
CEFUROXIME 500MG (TAB)
11/27/2025
12/01/2025
PO
500mg
BID
THICKLY MSAF
Waiting Final Action
11/27/2025
METRONIDAZOLE 500MG (TAB)
11/27/2025
12/01/2025
PO
500mg
TID
THICKLY MSAF
Waiting Final Action